FIELD: chemistry.
SUBSTANCE: invention relates to a compound of general formula (I):
,
where R1 represents a C1-6alkyl group, a C1-6alkoxyC1-6 alkyl group, a C3-6cycloalkyl group or a C3-6cycloalkyl C1-6alkyl group, R2 represents a hydrogen atom or a halogen group, R3 represents a hydrogen atom, a halogen group, a halogenC1-6alkyl group, a halogenC1-6alkoxy group, a saturated C1-5cyclic amino group, C1-6dialkylamino group, C3-6cycloalkyl C1-6alkoxy group or C1-6alkoxy group, A is a C3-6cycloalkyl ring, X is CH or N, Y is CH or N, Z is CH or N and n is an integer selected from 1, 2, 3 and 4, or a pharmaceutically acceptable salt thereof or a hydrate of the compound or a pharmaceutically acceptable salt thereof.
EFFECT: invention is used to prevent or treat hyperphosphataemia.
42 cl, 17 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED THEREON, USE THEREOF AND METHOD OF TREATING AND/OR PREVENTING DISEASE | 2009 |
|
RU2474575C2 |
2-PYRIDONE DERIVATIVES | 2010 |
|
RU2551847C2 |
SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2013 |
|
RU2607081C2 |
SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2014 |
|
RU2667520C9 |
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
NEW HYDROXAMIC ACID DERIVATIVE | 2011 |
|
RU2575129C2 |
CONDENSED 4-OXOPYRIMIDINE DERIVATIVE | 2005 |
|
RU2358969C2 |
BENZIMIDAZOLE DERIVATIVES, BASED PHARMACEUTICAL COMPOSITION AND METHODS OF USING THEM | 2008 |
|
RU2456276C2 |
NEW 2-HETEROARYL-SUBSTITUTE BENZIMIDAZOLE DERIVATIVE | 2004 |
|
RU2329261C2 |
CYCLIC AMINE COMPOUNDS | 2002 |
|
RU2299207C2 |
Authors
Dates
2018-07-31—Published
2014-04-23—Filed